产品名称 | NebuSelect™ Recombinant Mouse Glypican 2/GPC2, His-tag |
---|---|
目录号 | NBL-242559 |
别名 | Glypican 2/GPC2; Glypican-2; 2410016G05Rik; Cerebroglycan; GPC2 |
外观 | see COA |
分子量 | His22-Ser556 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q8BKV1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242559-100ug | 100ug | Inquire | Inquire | |
NBL-242559-1mg | 1mg | Inquire | Inquire | |
NBL-242559-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Mouse Glypican 2/GPC2, His-tag
Catalog#:
NBL-242559
Description:
NebuSelect™ Recombinant Mouse Glypican 2/GPC2, His-tag(Cat#NBL-242559) is expressed in HEK293 with His tag at the C-Terminus.It contains His22-Ser556.
Species:
Mouse
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 59.9 kDa. Due to autocatalytic cleavage, the protein migrates to 32-35 kDa based on Bis-Tris PAGE result.
Target Name:
Glypican 2/GPC2; Glypican-2; 2410016G05Rik; Cerebroglycan; GPC2
Target Information:
Glypicans can function as coreceptors for multiple signaling molecules known for regulating cell growth, motility, and differentiation. Some members of the glypican family, including glypican 2 (GPC2) and glypican 3 (GPC3), are expressed in childhood cancers and liver cancers, respectively. Antibody-based therapies targeting glypicans are being investigated in preclinical and clinical studies, with the goal of treating solid tumors that do not respond to standard therapies.
Amino Acid Sequence:
His22-Ser556
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.